Alia A Sarafandi Selected Research

Isoleucine-tRNA Ligase

5/2005	Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
10/2004	Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alia A Sarafandi Research Topics

Disease

2	Body Weight (Weight, Body) 05/2005 - 10/2004
2	Candidiasis (Moniliasis) 05/2005 - 10/2004
1	Central Nervous System Infections (Central Nervous System Infection) 05/2005
1	Infections 10/2004
1	Invasive Pulmonary Aspergillosis 06/2003
1	Lung Injury 06/2003
1	Pulmonary Aspergillosis 06/2003

Drug/Important Bio-Agent (IBA)

2	Isoleucine-tRNA LigaseIBA 05/2005 - 10/2004
2	2- amino- 4- methylenecyclopentane- 1- carboxylic acidIBA 05/2005 - 10/2004
2	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2005 - 10/2004
2	Fluconazole (Zonal)FDA LinkGeneric 05/2005 - 10/2004
1	Dihydrotachysterol (AT 10)IBA 05/2005
1	Micafungin (FK463)FDA Link 06/2003
1	TriazolesIBA 06/2003
1	EchinocandinsIBA 06/2003
1	ER 30346 (ravuconazole)IBA 06/2003

Therapy/Procedure

1	Injections 10/2004
1	Therapeutics 06/2003